663 related articles for article (PubMed ID: 27401905)
21. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
[TBL] [Abstract][Full Text] [Related]
22. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates.
Sahin K; Tekin A; Ozdas S; Akin D; Yapislar H; Dilek AR; Sonmez E
Ann Clin Microbiol Antimicrob; 2015 Oct; 14():44. PubMed ID: 26444537
[TBL] [Abstract][Full Text] [Related]
24. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
[TBL] [Abstract][Full Text] [Related]
25. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
Vlek AL; Frentz D; Haenen A; Bootsma HJ; Notermans DW; Frakking FN; de Greeff SC; Leenstra T;
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
[TBL] [Abstract][Full Text] [Related]
26. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
[TBL] [Abstract][Full Text] [Related]
27. Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.
Wang JT; Wu UI; Lauderdale TL; Chen MC; Li SY; Hsu LY; Chang SC
PLoS One; 2015; 10(3):e0121668. PubMed ID: 25794144
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs.
Patel TS; Nagel JL
J Clin Microbiol; 2015 Jan; 53(1):201-5. PubMed ID: 25378572
[TBL] [Abstract][Full Text] [Related]
29. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
30. Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.
Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):290-1. PubMed ID: 22521054
[No Abstract] [Full Text] [Related]
31. Evaluation of the Carba NP Test in Oregon, 2013.
Morey KE; Vega R; Cassidy PM; Buser GL; Rayar JK; Myers JA; Weissman SJ; Beldavs ZG; Pfeiffer CD
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795386
[TBL] [Abstract][Full Text] [Related]
32. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis.
Bogan C; Kaye KS; Chopra T; Hayakawa K; Pogue JM; Lephart PR; Bheemreddy S; Lazarovitch T; Zaidenstein R; Perez F; Bonomo RA; Marchaim D
Am J Infect Control; 2014 Jun; 42(6):612-20. PubMed ID: 24837111
[TBL] [Abstract][Full Text] [Related]
34. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
35. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
36. The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey.
Karabay O; Altindis M; Koroglu M; Karatuna O; Aydemir ÖA; Erdem AF
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():6. PubMed ID: 26860360
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a new rapid test for carbapenemase detection in carbapenem resistant Enterobacteriaceae.
Martino MD; Koga PC; Pasternak J; Doi AM; Ciola CS; da Silva CB; Massaia IF; da Silva IG; de Araújo MR
J Microbiol Methods; 2015 Aug; 115():20-1. PubMed ID: 25953145
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
39. KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States.
Pesesky MW; Hussain T; Wallace M; Wang B; Andleeb S; Burnham CA; Dantas G
Emerg Infect Dis; 2015 Jun; 21(6):1034-7. PubMed ID: 25988236
[TBL] [Abstract][Full Text] [Related]
40. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
